<--- Back to Details
First PageDocument Content
Drug discovery / Clinical research / Pharmaceutical industry / Toxicology / ETOX / Clinical trials / Quantitative structureactivity relationship / Pharmacovigilance / Drug development / Pre-clinical development / Validation / Food and Drug Administration
Date: 2016-03-30 09:11:20
Drug discovery
Clinical research
Pharmaceutical industry
Toxicology
ETOX
Clinical trials
Quantitative structureactivity relationship
Pharmacovigilance
Drug development
Pre-clinical development
Validation
Food and Drug Administration

Microsoft Word - eTOXNewsletter18v9

Add to Reading List

Source URL: www.etoxproject.eu

Download Document from Source Website

File Size: 254,60 KB

Share Document on Facebook

Similar Documents

SL-35: Oncology Phenotypic Screening. Macrocycles. Phenotypic screening is a firmly established technology that has contributed to the identification of valuable therapeutic agents in oncology drug discovery [1]. For exa

DocID: 1voSH - View Document

Seminars on Drug Discovery & Development Wednesdays 17::00, Lecture Hall 1, Pharmazentrum, Klingelbergstrasse 50, Basel Feb 24, 16 Prof. Dr. G. Klebe, Institute of Pharmaceutical Chemistry, Philipps-University Mar

DocID: 1vnYL - View Document

THE SCIENCE OF BETTER MEDICINES The Harvard Program in Therapeutic Science (HiTS) is building partnerships and developing new ideas and technologies to advance drug discovery and precision medicine.

DocID: 1vnKo - View Document

Scientific Program conferenceseries.com 3rd International Conference and Expo on Drug Discovery & Designing

DocID: 1vngF - View Document

5th CDDD Meeting COMPUTATIONALLY DRIVEN DRUG DISCOVERY November 16-17, 2017 | IFOM, Milan - Italy

DocID: 1vkVj - View Document